Gelberg J, Kongstad L, Werner O
Department of Paediatric Anaesthesia and Intensive Care, Children's Hospital, Skane University Hospital, Lund University, Lund, Sweden.
Acta Anaesthesiol Scand. 2014 Aug;58(7):820-5. doi: 10.1111/aas.12346. Epub 2014 Jun 5.
Bolus injections of intravenous propofol and remifentanil can be used in the tracheal intubation of infants and children, but relatively large doses are needed. We hypothesised that addition of a small bolus of rocuronium would ensure good intubation conditions when modest propofol and remifentanil doses were used.
Seventy infants between 3 weeks and 4 months of age were randomised to receive either placebo or rocuronium. Anaesthesia was induced with IV propofol, 3 (3-5) mg/kg [median (range)]. Rocuronium (0.2 mg/kg) or placebo was then injected, followed 15 s later by 2 μg/kg remifentanil. One anaesthetist attempted tracheal intubation 1 min after the rocuronium/placebo injection and used the 'Copenhagen scoring system' to assess intubation conditions. The neuromuscular effect of 0.2 mg/kg rocuronium was recorded in another eight, already intubated, infants using thumb accelerometry during train-of-four stimulation of the ulnar nerve.
Intubation conditions were classified as 'poor' in 14 of 34 (41%) patients given placebo and in 10 of 36 (28%) patients given rocuronium (P = 0.32). There were four failed first attempts at intubation in the placebo group and none in the rocuronium group (P = 0.051). Maximum neuromuscular depression occurred 4 (3-8) after injection of 0.2 mg/kg rocuronium.
Intubation conditions were poor in almost one third of the patients receiving propofol-remifentanil. Adding a low-dose rocuronium did not significantly improve intubation conditions.
静脉注射丙泊酚和瑞芬太尼推注可用于婴幼儿气管插管,但需要相对较大剂量。我们假设,在使用适度剂量的丙泊酚和瑞芬太尼时,添加一小剂量的罗库溴铵可确保良好的插管条件。
70名3周龄至4月龄的婴儿被随机分为接受安慰剂或罗库溴铵组。静脉注射丙泊酚3(3 - 5)mg/kg[中位数(范围)]诱导麻醉。然后注射罗库溴铵(0.2mg/kg)或安慰剂,15秒后注射2μg/kg瑞芬太尼。一名麻醉医生在注射罗库溴铵/安慰剂1分钟后尝试气管插管,并使用“哥本哈根评分系统”评估插管条件。在另外8名已插管的婴儿中,使用拇指加速度计在尺神经四个成串刺激期间记录0.2mg/kg罗库溴铵的神经肌肉效应。
34名接受安慰剂的患者中有14名(41%)插管条件被分类为“差”,36名接受罗库溴铵的患者中有10名(28%)插管条件被分类为“差”(P = 0.32)。安慰剂组有4例首次插管失败,罗库溴铵组无失败病例(P = 0.051)。注射0.2mg/kg罗库溴铵后4(3 - 8)分钟出现最大神经肌肉抑制。
接受丙泊酚 - 瑞芬太尼的患者中近三分之一插管条件较差。添加低剂量罗库溴铵并未显著改善插管条件。